{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:26:11Z","timestamp":1790310371679,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T00:00:00Z","timestamp":1610496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T00:00:00Z","timestamp":1610496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s10072-020-04970-w","type":"journal-article","created":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T03:47:03Z","timestamp":1610596023000},"page":"3681-3686","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Effect of pyridoxine plus pyridostigmine treatment on vincristine-induced peripheral neuropathy in pediatric patients with acute lymphoblastic leukemia: a single-center experience"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8801-7776","authenticated-orcid":false,"given":"Sultan","family":"Aydin K\u00f6ker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salih","family":"G\u00f6zmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beng\u00fc","family":"Demira\u011f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aycan","family":"\u00dcnalp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuba Hilkay","family":"Karapinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye\u015fim","family":"Oymak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcrkan","family":"G\u00fcrb\u00fcz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ecem \u0130pek","family":"\u00d6ner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raziye Canan","family":"Vergin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,13]]},"reference":[{"key":"4970_CR1","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1002\/1097-0142(19950415)75:8<2186::AID-CNCR2820750825>3.0.CO;2-F","volume":"75","author":"JG Gurney","year":"1995","unstructured":"Gurney JG, Severson RK, Davis S, Robison LL (1995) Incidence of cancer in children in the United States: sex-, race-, and 1-year age-specific rates by histologic type. Cancer 75:2186\u20132195","journal-title":"Cancer"},{"key":"4970_CR2","first-page":"2","volume-title":"Priciples and Practice of Pediatric Oncology","author":"JG Gurney","year":"2006","unstructured":"Gurney JG, Bondy ML (2006) Epidemiology of childhood cancer. In: Pizzo PA, Poplack DG (eds) Priciples and Practice of Pediatric Oncology, 5th edn. Lippincott Williams and Wilkins, Philadelphia, pp 2\u201314","edition":"5"},{"key":"4970_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/PL00007853","volume":"249","author":"S Quasthoff","year":"2002","unstructured":"Quasthoff S, Hartung HP (2002) Chemotherapy induced peripheral neuropathy. J Neurol 249:9\u201317","journal-title":"J Neurol"},{"key":"4970_CR4","first-page":"19","volume":"31","author":"V Toopchizade","year":"2010","unstructured":"Toopchizade V, Hosseini M (2010) Electrophysiological signs of neuropathy caused by vincristine. Medical Journal of Tabriz University of Medical Sciences 31:19\u201325","journal-title":"Medical Journal of Tabriz University of Medical Sciences"},{"key":"4970_CR5","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0305-7372(94)90027-2","volume":"20","author":"MK Tuxen","year":"1994","unstructured":"Tuxen MK, Hansen SW (1994) Complication of treatment, Neurotoxicity secondary to antineoplastic drugs. Cancer Treat Rev 20:191\u2013214","journal-title":"Cancer Treat Rev"},{"key":"4970_CR6","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1023\/A:1008369315240","volume":"11","author":"G Hildebrandt","year":"2000","unstructured":"Hildebrandt G, Holler E, Woenkhaus M, Quarch G, Reichle A, Schalke B, Andreesen R (2000) Acute deterioration of Charcot\u2013Marie\u2013Tooth disease 1A (CMT 1A) following 2 mg of vincristine chemotherapy. Ann Oncol 11:743\u2013747","journal-title":"Ann Oncol"},{"key":"4970_CR7","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1200\/JCO.2013.49.1514","volume":"31","author":"F Mols","year":"2013","unstructured":"Mols F, Beijers T, Lemmens V, van den Hurk CJ, Vreugdenhil G, van de Poll-Franse LV (2013) Chemotherapy-induced neuropathy and its association with quality of life among 2- to 11-year colorectal cancer survivors: results from the population based PROFILES registry. J Clin Oncol 31:2699\u20132707","journal-title":"J Clin Oncol"},{"key":"4970_CR8","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1200\/JCO.2013.52.0536","volume":"32","author":"CL Loprinzi","year":"2014","unstructured":"Loprinzi CL, Qin R, Dakhil SR, Fehrenbacher L, Flynn KA, Atherton P, Seisler D, Qamar R, Lewis GC, Grothey A (2014) Phase III randomized, placebo-controlled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin induced sensory neurotoxicity (N08CB\/Alliance). J Clin Oncol 32:997\u20131005","journal-title":"J Clin Oncol"},{"key":"4970_CR9","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1200\/JCO.2013.54.0914","volume":"32","author":"DL Hershman","year":"2014","unstructured":"Hershman DL, Lacchetti C, Dworkin RH, Lavoie Smith EM, Bleeker J, Cavaletti G, Chauhan C, Gavin P, Lavino A, Lustberg MB, Paice J, Schneider B, Smith ML, Smith T, Terstriep S, Wagner-Johnston N, Bak K, Loprinzi CL, American Society of Clinical Oncology (2014) Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 32:1941\u20131967","journal-title":"J Clin Oncol"},{"key":"4970_CR10","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1080\/08880010701451327","volume":"24","author":"H Ozyurek","year":"2007","unstructured":"Ozyurek H, Turker H, Akbalik M, Bayrak AO, Ince H, Duru F (2007) Pyridoxine and pyridostigmine treatment in vincristine-induced neuropathy. Pediatr Hematol Oncol 24:447\u2013452","journal-title":"Pediatr Hematol Oncol"},{"key":"4970_CR11","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1200\/JCO.1986.4.8.1277","volume":"4","author":"AM Castellanos","year":"1986","unstructured":"Castellanos AM, Fields WS (1986) Grading of neurotoxicity in cancer therapy. J Clin Oncol 4:1277\u20131278","journal-title":"J Clin Oncol"},{"key":"4970_CR12","doi-asserted-by":"crossref","unstructured":"Basch E, Reeve BB, Mitchell SA et al (2014). Development of the National Cancer Institute\u2019s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). J Nalt Cancer Inst 106","DOI":"10.1093\/jnci\/dju244"},{"key":"4970_CR13","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1001\/jamaoncol.2015.2639","volume":"1","author":"AC Dueck","year":"2015","unstructured":"Dueck AC, Mendoza TR, Mitchell SA, Reeve BB, Castro KM, Rogak LJ, Atkinson TM, Bennett AV, Denicoff AM, O'Mara AM, Li Y, Clauser SB, Bryant DM, Bearden JD 3rd, Gillis TA, Harness JK, Siegel RD, Paul DB, Cleeland CS, Schrag D, Sloan JA, Abernethy AP, Bruner DW, Minasian LM, Basch E, National Cancer Institute PRO-CTCAE Study Group (2015) Validity and reliability of the US National Cancer Institute\u2019s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). JAMA Oncol 1:1051\u20131059","journal-title":"JAMA Oncol"},{"key":"4970_CR14","first-page":"619","volume":"12","author":"AJ Ocean","year":"2004","unstructured":"Ocean AJ, Vhadat LT (2004) Chemotherapy-induced peripheral neuropathy: pathogenesis and emerging therapies. Support Care Cancer 12:619\u2013625","journal-title":"Support Care Cancer"},{"key":"4970_CR15","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/BF02759902","volume":"73","author":"A Bay","year":"2006","unstructured":"Bay A, Yilmaz C, Yilmaz N, Oner AF (2006) Vincristine induced cranial polyneuropathy. Indian J Pediatr 73:531\u2013533","journal-title":"Indian J Pediatr"},{"key":"4970_CR16","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1002\/mpo.2950170534","volume":"17","author":"S McGuire","year":"1989","unstructured":"McGuire S, Gospe S, Dahl G (1989) Acute vincristine neurotoxicity in the presence of motor and sensory neuropathy type 1. Med Pediatr Oncol 17:520\u2013523","journal-title":"Med Pediatr Oncol"},{"key":"4970_CR17","first-page":"66","volume":"8","author":"A Talebian","year":"2014","unstructured":"Talebian A, Goudarzi RM, Mohammadzadeh M, Mirzadeh AS (2014) Vincristine-Induced Cranial Neuropathy. Iran J Child Neurol 8:66\u201368","journal-title":"Iran J Child Neurol"},{"key":"4970_CR18","doi-asserted-by":"publisher","first-page":"e194","DOI":"10.1016\/j.leukres.2010.01.026","volume":"34","author":"N Ngamphaiboon","year":"2010","unstructured":"Ngamphaiboon N, Sweeney R, Wetzler M, Wang ES (2010) Pyridoxine treatment of vincristine-induced cranial polyneuropathy in an adult patient with acute lymphocytic leukemia: case report and review of the literature. Leuk Res 34:e194\u2013e196","journal-title":"Leuk Res"},{"key":"4970_CR19","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/pbc.10301","volume":"42","author":"L M\u00fcller","year":"2004","unstructured":"M\u00fcller L, Kramm CM, Tenenbaum T, Wessalowski R, G\u00f6bel U (2004) Treatment of vincristine-induced bilateral ptosis with pyridoxine and pyridostigmine. Pediatr Blood Cancer 42:287\u2013288","journal-title":"Pediatr Blood Cancer"},{"key":"4970_CR20","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s002800050723","volume":"41","author":"J Cassidy","year":"1998","unstructured":"Cassidy J, Paul J, Soukop M, Habeshaw T, Reed NS, Parkin D, Kaye SB (1998) Clinical trials of nimodipine as a potential neuroprotector in ovarian cancer patients treated with cisplatin. Cancer Chemother Pharmacol 41:161\u2013166","journal-title":"Cancer Chemother Pharmacol"},{"key":"4970_CR21","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1200\/JCO.2003.05.139","volume":"21","author":"BA Pace","year":"2003","unstructured":"Pace BA, Savarese A, Picardo M (2003) Neuroprotective effect of vitamin E supplementation in patients treated with cisplatin chemotherapy. J Clin Oncol 21:927\u2013931","journal-title":"J Clin Oncol"},{"key":"4970_CR22","doi-asserted-by":"publisher","first-page":"4465","DOI":"10.7314\/APJCP.2015.16.10.4465","volume":"16","author":"M-Y Liu","year":"2015","unstructured":"Liu M-Y, Huang X-E (2015) Effects of analgecine on oxaliplatin-\u0131nduced neurotoxicity in patients with gastrointestinal cancer. Asian Pac J Cancer Prev 16:4465\u20134468","journal-title":"Asian Pac J Cancer Prev"},{"key":"4970_CR23","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1002\/1097-0142(19940515)73:10<2515::AID-CNCR2820731011>3.0.CO;2-G","volume":"73","author":"N Haim","year":"1994","unstructured":"Haim N, Epelbaum R, Ben-Shahar M, Yarnitsky D, Simri W, Robinson E (1994) Full dose vincristine (without 2-mg dose limit) in the treatment of lymphomas. Cancer 73:2515\u20132519","journal-title":"Cancer"},{"key":"4970_CR24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/BF01050259","volume":"15","author":"TJ Postma","year":"1993","unstructured":"Postma TJ, Benard BA, Huijgens PC, Ossenkoppele GJ, Heimans JJ (1993) Long-term effects of vincristine on the peripheral nervous system. J Neuro-Oncol 15:23\u201327","journal-title":"J Neuro-Oncol"},{"key":"4970_CR25","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/j.1529-8027.2009.00230.x","volume":"14","author":"S Ramchandren","year":"2009","unstructured":"Ramchandren S, Leonard M, Mody RJ, Donohue JE, Moyer J, Hutchinson R, Gurney JG (2009) Peripheral neuropathy in survivors of childhood acute lymphoblastic leukemia. J Peripher Nerv Syst 14:184\u2013189","journal-title":"J Peripher Nerv Syst"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-020-04970-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-020-04970-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-020-04970-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T18:37:37Z","timestamp":1630694257000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-020-04970-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,13]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["4970"],"URL":"https:\/\/doi.org\/10.1007\/s10072-020-04970-w","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,13]]},"assertion":[{"value":"25 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethics committee approval was obtained from Dr. Beh\u00e7et Uz Children's hospital on 24.12.2015 (protocol number:2015\/51).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}